Latest News and Press Releases
Want to stay updated on the latest news?
-
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
-
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Medzown (“Medzown” or the “Company”), a precision medicine management company focused on improving access to advanced therapies and clinical trials for...
-
Internationally recognized radiopharmaceutical leader joins Actithera as the lead FAP-targeting asset advances to clinical development and the differentiated pipeline takes shapeBrings over 15 years...
-
SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system,...
-
InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer
-
Omada Health welcomes Thomas Tsang, MD, MPH as Chief Medical Officer
-
Company strengthens its late-stage trials with enhanced clinical and commercial leadership for its BPM31510 programs
-
PRESS RELEASE CHARM Therapeutics Appoints Dr Erkut Bahceci as Chief Medical Officer LONDON – 8 September 2025 -- CHARM Therapeutics (“CHARM”, “The Company”), announces the appointment of Dr Erkut...
-
CHICAGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics, the first outpatient pediatric destination purpose-built to provide elevated, seamlessly coordinated primary and specialty care...
-
Complement 1, today announced the appointment of Dr. Christopher Cogle as its new Chief Medical Officer (CMO).